138 dependent cellular oxidoreductase enzymes. Twenty-four hours after treatment of BeWo cells 139 with DMSO (vehicle control), melatonin 1mM, rapamycin 300 nM or 3-MA 5 mM under 140 normoxia or H/R, 10 µl of MTT, at a final concentration of 5 mg/ml, was added to the media. 141 Four hours after incubation, 100 µl Solubilisation solution (40% (vol/vol) dimethylformamide in 142 2% (vol/vol) glacial acetic acid) was added to each well to dissolve formazan crystals. After 143 mixing to ensure complete solubilisation, MTT formazan absorbance at 570 nm was measured 144 using with Spectra Max M5 (Molecular Devices). Results are presented as a percent of vehicle 145 control (DMSO). To analyze protein expression, BeWo cells and primary vCTB were rinsed with PBS and 157 lysed with ice-cold modified radioimmunoprecipitation (RIPA) buffer (50 mmol/l Tris-HCl pH 158 7.4, 1% NP-40, 0,25% Na-deoxycholate, 150 mmol/l NaCl and 1 mmol/l EDTA) containing 159 protease and phosphatase inhibitors (Sigma-Aldrich). Protein concentration was determined 160 using the bicinchoninic acid (BCA) protein assay reagent (Pierce Biotechnology, Waltham, MA). 161 Twenty µg of protein were separated on Mini-PROTEAN® TGX™ Precast Protein Gels (4-15% 162 precast polyacrylamide gel) (Bio-Rad, Saint-Laurent, QC, Canada), followed by transfer to 163 Polyvinylidene fluoride (PVDF) membranes (Bio-Rad). Membranes were then incubated with 164 antibodies as described in Table 1 . Blots were developed with enhanced chemiluminescence 165 reagent (Bio-Rad). Protein levels were expressed as a ratio of a specific band density and total 166 protein stained using Pierce™ Reversible Protein Stain Kit (Pierce Biotechnology), as previously 167 described [26, 27] . Bands were quantified using Image Lab software 6.0 (Bio-Rad). 
Secondary antibodies
Anti-goat-HRP 1:10 000 1 h, RT Millipore (AP180P)
Anti-mouse-HRP 1:10 000 1 h, RT Millipore (AP192P)
Anti-rabbit-HRP 1:10 000 1 h, RT Millipore (AP182P) 
